Evidence map›Paper›PMID 35207471›Full record

ArticleLife (Basel, Switzerland)2022

Retinal Disease and Metabolism.

Zhongjie Fu, Ayumi Usui-Ouchi, William Allen, Yohei Tomita

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhongjie FuDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-8182-2983
Ayumi Usui-OuchiDepartment of Ophthalmology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.ORCID 0000-0003-2974-0830
William AllenDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Yohei TomitaDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-1013-5737

Funding

Serine control of retinal neovascularization in retinopathyR01EY032492 · NEI · BOSTON CHILDREN'S HOSPITAL · PI FU, ZHONGJIE · 2021 to 2025
$2.2M
Alcon Research Institute Alcon Research InstituteBert M. Glaser, MD Award Bert M. Glaser, MD AwardBoston Children's Hospital OFD/BTREC/CTREC Faculty Career Development Grant, Pilot Grant, and Ophthalmology Foun-dationJapan Society for the Promotion of Science 17K16984Japan Society for the Promotion of Science 21K09727Manpei Suzuki Diabetes Foundation Manpei Suzuki Diabetes FoundationMass Lions Eye Foundation Mass Lions Eye FoundationNEI NIH HHS 1R01EY032492NEI NIH HHS R01 EY032492
6 · The paper itself

Abstract

Retinal diseases, such as diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinopathy of prematurity (ROP), are some of the leading causes of blindness all over the world [...].

Identifiers

PMID35207471
PMCPMC8879522

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.